We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP38449
Abstract: • A comprehensive characterization of therapeutic mAbs is critical. PTMs including oxidation, deamidation, glycosylation may significantly alter the efficacy and safety of the protein drug.
• Regulatory agencies require a full characterization of the biological and chemical heterogeneity of any biological drug product.
• This work focuses on the utility of the maXis II UHR QTOF for rapid screening of mAbs at the intact protein and peptide level for sequence characterization and MAM analysis.
• The automated workflow is implemented using BioPharma Compass software which encompasses data acquisition, processing and reporting using a seamless workflow solution.Summary: This work focuses on the utility of the maXis II UHR QTOF for rapid screening of mAbs at the intact protein and peptide level for sequence characterization and MAM analysis.
• Regulatory agencies require a full characterization of the biological and chemical heterogeneity of any biological drug product.
• This work focuses on the utility of the maXis II UHR QTOF for rapid screening of mAbs at the intact protein and peptide level for sequence characterization and MAM analysis.
• The automated workflow is implemented using BioPharma Compass software which encompasses data acquisition, processing and reporting using a seamless workflow solution.Summary: This work focuses on the utility of the maXis II UHR QTOF for rapid screening of mAbs at the intact protein and peptide level for sequence characterization and MAM analysis.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Development of QSP model of COVID-19 based on Immune Response Template
Veronika Musatova, Oleg Demin, Maria Kupriyanova, Anna Viktorenko
Active Pharmaceutical Ingredient Analysis
Tylor
Comparison of Caco-2 with Other Cell-based Models
Hannah Cole
Dry Powder Inhalation Excipients
Helen Smith
Penetration Enhancer Excipients
Helen Smith